Pre-COVID-19* N=15 months | During COVID-19 N=9 months | |||
Average per month | SD | Average per month | SD | |
Reproductive and maternal healthcare* | ||||
No of visits for contraceptives | 43 270 | 7325 | 19 136 | 3217 |
No of antenatal care visits | 285 007 | 17 494 | 196 455 | 10 039 |
No of facility deliveries (incl. caesarean sections) | 32 634 | 3345 | 26 099 | 1366 |
Caesarean section rate (%) | 45.18 | 0.86 | 46.86 | 0.84 |
Child healthcare | ||||
No of consultations for sick children† | 11 482 | 3321 | 2737 | 579 |
No of childhood vaccinations administered‡ | 97 729 | 11 615 | 49 307 | 11 130 |
Chronic diseases care | ||||
No of women screened for cervical cancer§ | 216 808 | 15 826 | 84 752 | 26 005 |
No of women screened for breast cancer ¶ | 77 436 | 8933 | 29 964 | 15 106 |
No of consultations for diabetes care | 1 335 635 | 63 419 | 926 302 | 126 467 |
Proportion of patients with diabetes with controlled condition (%) | 35.68 | 1.22 | 26.38 | 2.35 |
No of consultations for hypertension care | 1 414 592 | 126 182 | 1 016 122 | 175 488 |
Proportion of patients with hypertension with controlled condition (%) | 67.83 | 6.80 | 54.76 | 8.71 |
*The pre-COVID-19 period is January 2019 to March 2020. The COVID-19 period includes April to December 2020.
†Includes consultations for diarrhoea, pneumonia and malnutrition in children under 5.
‡Number of children who received a unique dose of BCG vaccine, a third dose of pentavalent vaccine, a second dose of measles, mumps and rubella vaccine, a second dose of rotavirus vaccine and a third dose of the pneumococcal conjugate vaccine.
§Number of women aged 25–64 affiliated with IMSS screened with VIA for cervical cancer for the first time.
¶Number of women aged 50–69 affiliated with IMSS screened for breast cancer with a mammography for the first time.